Clorox (NYSE: CLX ) is expected to report Q4 earnings around Aug. 3. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 3.4% and EPS will improve 0.8%.
The average estimate for revenue is $1.53 billion. On the bottom line, the average EPS estimate is $1.27.
Last quarter, Clorox logged revenue of $1.40 billion. GAAP reported sales were 7.4% higher than the prior-year quarter's $1.30 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.02. GAAP EPS of $1.00 for Q3 were 8.3% lower than the prior-year quarter's $1.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.3%, 180 basis points worse than the prior-year quarter. Operating margin was 16.1%, 220 basis points worse than the prior-year quarter. Net margin was 9.4%, 220 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.46 billion. The average EPS estimate is $4.07.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 827 members out of 866 rating the stock outperform, and 39 members rating it underperform. Among 278 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 271 give Clorox a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $69.64.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.